MyFinsight
Home
Blog
About
Contact
Download
Download image
Net (loss) income
-$10,584K
Net (loss) income
from continuing...
-$10,584K
ADHDPortfolio
$13,216K
The Pediatric
Portfolio
$1,689K
EXXUAPortfolio
$241K
Product And Service
Other
$19K
(loss) income from
continuing operations...
-$10,584K
Other income, net
$190K
Net revenue
$15,165K
Derivative warrant
liabilities (loss) gain
-$8,244K
Loss from operations
-$1,970K
Interest expense
$560K
Gross profit
$9,624K
Cost of goods sold
$5,541K
Total operating
expenses
$11,594K
Selling and marketing
$5,998K
General and
administrative
$5,070K
Amortization of intangible
assets
$526K
Back
Back
Income Statement
source: myfinsight.com
AYTU BIOPHARMA, INC (AYTU)
AYTU BIOPHARMA, INC (AYTU)